Alyeska Investment Group’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-676,445
Closed -$31.4M 530
2018
Q3
$31.4M Buy
676,445
+626,251
+1,248% +$30.3M 0.34% 94
2018
Q2
$2.42M Sell
50,194
-167,612
-77% -$8.02M 0.02% 338
2018
Q1
$9.43M Sell
217,806
-858,114
-80% -$38.5M 0.08% 237
2017
Q4
$42.7M Buy
1,075,920
+168,305
+19% +$7.01M 0.34% 96
2017
Q3
$39.4M Buy
907,615
+428,163
+89% +$19.5M 0.29% 111
2017
Q2
$22.9M Sell
479,452
-75,342
-14% -$3.51M 0.19% 153
2017
Q1
$22.8M Buy
554,794
+169,478
+44% +$7.07M 0.19% 173
2016
Q4
$14.8M Buy
+385,316
New +$15.6M 0.12% 241
2016
Q1
Sell
-103,490
Closed -$6.55M 488
2015
Q4
$6.55M Buy
+103,490
New +$7.05M 0.07% 243
2015
Q3
Sell
-178,116
Closed -$12.1M 567
2015
Q2
$12.1M Sell
178,116
-115,770
-39% -$6.39M 0.14% 201
2015
Q1
$12.5M Buy
+293,886
New +$13.1M 0.17% 201

Other funds holding IMPV

Alyeska Investment Group's IMPV Position: Q4 2018 in Review

Alyeska Investment Group sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 676,445 shares — an estimated $31.4M sold.

Alyeska Investment Group first reported a position in IMPV in Q1 2015 and held it in 11 quarters. The position peaked at $42.7M in Q4 2017. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Alyeska Investment Group reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 676,445 Imperva, Inc. shares in Q4 2018, an estimated $31.4M.
  • Alyeska Investment Group first reported a position in Imperva, Inc. in Q1 2015 and held it in 11 quarters.
  • Alyeska Investment Group's Imperva, Inc. position peaked at $42.7M in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Alyeska Investment Group's 13F filing for Q4 2018, filed 14 Feb 2019.